ADA and parasitic infectious disease: Targeting adenosine and detecting ADA level can help us to monitor the progression of patients from early parasitemia in asymptomatic VL to clinical disease, since IL-10 was observed in high concentration, during conversion into clinical disease; IL-10 level concurrent to serum ADA activity can help to facilitate early intervention and interruption of disease transmission.